Search

Captodiame

Captodiame has been suggested for use in preventing benzodiazepine withdrawal syndrome. … Captodiame, also known as captodiamine, is an antihistamine which is used as a sedative and anxiolytic. It is a derivative of diphenhydramine.

MK-0354

MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. … It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.

Besigomsin

Besigomsin is a small molecule drug. Besigomsin has a monoisotopic molecular weight of 416.18 Da.

Mizolastine

Mizolastine is under investigation in clinical trial NCT01928316 (A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers).

AGS-004

This approach may overcome the weaknesses of other available therapies and therefore could result in a better chance of success for HIV treatment. … AGS-004 is a personalized RNA-loaded dendritic cellbased immunotherapy that is designed to stimulate the patient’s immune system to target and destroy the patient’s own unique viral burden.

Benzoin

Benzoin is a white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide, and is used in organic syntheses. … Benzoin is an FDA-approved colour additive used for marking fruits and vegetables.

DA-697b

DA-967b is an investigational antiplatelet agent that inhibits collagen and ristocetin-mediated platelet activation.

FP-1096

FP1096 reduced the painful symptoms of endometriosis in trial subjects with very minimal side effect.

SAR-260301

TJ003234